Stéphane Bourg

1.2k total citations
42 papers, 987 citations indexed

About

Stéphane Bourg is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Stéphane Bourg has authored 42 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Organic Chemistry and 10 papers in Computational Theory and Mathematics. Recurrent topics in Stéphane Bourg's work include Computational Drug Discovery Methods (10 papers), Click Chemistry and Applications (6 papers) and Synthesis and biological activity (5 papers). Stéphane Bourg is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Click Chemistry and Applications (6 papers) and Synthesis and biological activity (5 papers). Stéphane Bourg collaborates with scholars based in France, Morocco and United States. Stéphane Bourg's co-authors include Pascal Bonnet, Christophe Meyer, Jean‐Marc Nuzillard, Sylvain Routier, Lionel Colliandre, Gérald Guillaumet, Laurent Meijer, Olivier Lozach, Frédéric Buron and Luc Morin‐Allory and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

Stéphane Bourg

40 papers receiving 945 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Stéphane Bourg 470 465 177 95 84 42 987
Istvan Enyedy 870 1.9× 364 0.8× 337 1.9× 141 1.5× 47 0.6× 46 1.3k
Cynthia D. Sommers 566 1.2× 152 0.3× 83 0.5× 177 1.9× 62 0.7× 39 1.1k
Arthur M. Doweyko 674 1.4× 783 1.7× 533 3.0× 158 1.7× 106 1.3× 47 1.6k
Laura Maccari 337 0.7× 225 0.5× 117 0.7× 119 1.3× 39 0.5× 24 662
Steven E. Hall 952 2.0× 574 1.2× 124 0.7× 126 1.3× 53 0.6× 40 1.5k
Dieter Dorsch 381 0.8× 368 0.8× 95 0.5× 91 1.0× 43 0.5× 40 950
Ana Conejo‐García 599 1.3× 404 0.9× 85 0.5× 127 1.3× 76 0.9× 61 998
Luisa Mosti 626 1.3× 1.5k 3.3× 108 0.6× 119 1.3× 84 1.0× 125 2.0k
Peter Hunt 519 1.1× 220 0.5× 273 1.5× 119 1.3× 88 1.0× 42 1.0k
Harold G. Selnick 689 1.5× 843 1.8× 118 0.7× 44 0.5× 28 0.3× 50 1.6k

Countries citing papers authored by Stéphane Bourg

Since Specialization
Citations

This map shows the geographic impact of Stéphane Bourg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Bourg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Bourg more than expected).

Fields of papers citing papers by Stéphane Bourg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Bourg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Bourg. The network helps show where Stéphane Bourg may publish in the future.

Co-authorship network of co-authors of Stéphane Bourg

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Bourg. A scholar is included among the top collaborators of Stéphane Bourg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Bourg. Stéphane Bourg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tortorella, Micky D., Stéphane Bach, Stéphane Bourg, et al.. (2022). Design and biological evaluation of substituted 5,7-dihydro-6 H -indolo[2,3- c ]quinolin-6-one as novel selective Haspin inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1632–1650. 5 indexed citations
2.
Buron, Frédéric, Nuno F. Rodrigues, Marie‐Aude Hiebel, et al.. (2021). Design, Synthesis and SAR in 2,4,7-Trisubstituted Pyrido[3,2-d]Pyrimidine Series as Novel PI3K/mTOR Inhibitors. Molecules. 26(17). 5349–5349.
3.
Kazzouli, Saı̈d El, Stéphane Bourg, Samia Aci‐Sèche, et al.. (2021). Palladium‐Catalyzed Regioselective C−H Arylation of 4‐Azaindazole at C3, C5 and C7 Positions. Advanced Synthesis & Catalysis. 363(16). 3937–3945. 7 indexed citations
4.
Aci‐Sèche, Samia, et al.. (2020). Comparative Assessment of Protein Kinase Inhibitors in Public Databases and in PKIDB. Molecules. 25(14). 3226–3226. 50 indexed citations
5.
Coste, F, Vincent Roy, Stéphane Bourg, et al.. (2020). Thiopurine Derivative-Induced Fpg/Nei DNA Glycosylase Inhibition: Structural, Dynamic and Functional Insights. International Journal of Molecular Sciences. 21(6). 2058–2058. 7 indexed citations
6.
Bosc, Nicolas, Christophe Müller, Laurent Hoffer, et al.. (2020). Fr-PPIChem: An Academic Compound Library Dedicated to Protein–Protein Interactions. ACS Chemical Biology. 15(6). 1566–1574. 29 indexed citations
8.
Bourg, Stéphane, et al.. (2018). PKIDB: A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials. Molecules. 23(4). 908–908. 137 indexed citations
9.
Bourg, Stéphane, et al.. (2017). VSPrep: A General KNIME Workflow for the Preparation of Molecules for Virtual Screening. Molecular Informatics. 36(10). 23 indexed citations
10.
Bourg, Stéphane, Pascal Bonnet, Christiane Guguen‐Guillouzo, et al.. (2016). Novel optimization of valmerins (tetrahydropyrido[1,2-a]isoindolones) as potent dual CDK5/GSK3 inhibitors. European Journal of Medicinal Chemistry. 115. 311–325. 16 indexed citations
11.
Roy, Vincent, Mathieu Métifiot, Christophe Marchand, et al.. (2015). Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integrase. European Journal of Medicinal Chemistry. 104. 127–138. 28 indexed citations
12.
Bourg, Stéphane, et al.. (2013). Synthesis and properties of 2′-O-neopentyl modified oligonucleotides. Organic & Biomolecular Chemistry. 11(8). 1345–1345. 3 indexed citations
13.
Grosse, Sandrine, Stéphane Massip, J.-M. Léger, et al.. (2012). Efficient Synthesis and First Regioselective C‐3 Direct Arylation of Imidazo[1,2‐b]pyrazoles. Chemistry - A European Journal. 18(47). 14943–14947. 23 indexed citations
14.
Chabot, Guy G., et al.. (2012). In vitro and in vivo biological evaluation of new 4,5-disubstituted 1,2,3-triazoles as cis-constrained analogs of combretastatin A4. European Journal of Medicinal Chemistry. 54. 22–32. 36 indexed citations
15.
Guilloux, Vincent Le, Alban Arrault, Lionel Colliandre, et al.. (2012). Mining collections of compounds with Screening Assistant 2. Journal of Cheminformatics. 4(1). 20–20. 24 indexed citations
16.
Pontikis, Renée, et al.. (2012). Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4. Bioorganic & Medicinal Chemistry. 21(5). 1357–1366. 23 indexed citations
17.
Novoa, Alexandre, Nadia Pellegrini-Moïse, Stéphane Bourg, et al.. (2011). Design, synthesis and antiproliferative activities of biarylolefins based on polyhydroxylated and carbohydrate scaffolds. European Journal of Medicinal Chemistry. 46(9). 3570–3580. 17 indexed citations
18.
Pontikis, Renée, Guy G. Chabot, Johanne Séguin, et al.. (2011). Synthesis and Structure–Activity Relationships of Constrained Heterocyclic Analogues of Combretastatin A4. ChemMedChem. 6(9). 1693–1705. 21 indexed citations
19.
Prost, Élise, Stéphane Bourg, & Jean‐Marc Nuzillard. (2005). Automatic first-order multiplet analysis in liquid-state NMR. Comptes Rendus Chimie. 9(3-4). 498–502. 2 indexed citations
20.
Lacquement, Jérôme, Annabelle Laplace, Olivier Conocar, et al.. (2003). Assessment of pyrochemical processes at CEA: Objectives and current results. SPIRE - Sciences Po Institutional REpository.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026